Skip to main content
Top
Published in: BMC Infectious Diseases 1/2019

Open Access 01-12-2019 | Hepatitis B | Research article

High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique

Authors: Cynthia Semá Baltazar, Roberta Horth, Makini Boothe, Isabel Sathane, Peter Young, Denise Chitsondzo Langa, Manuel Condula, Helena Ricardo, Liliana Dengo Baloi, Beverley Cummings, Nicolas Schaad, Lídia Gouveia, Eugénia Teodoro, Henry F. Raymond

Published in: BMC Infectious Diseases | Issue 1/2019

Login to get access

Abstract

Background

Few countries in sub-Saharan Africa know the magnitude of their HIV epidemic among people who inject drugs (PWID). This was the first study in Mozambique to measure prevalence of HIV, HBV, and HCV, and to assess demographic characteristics and risk behaviors in this key population.

Methods

We used respondent-driven sampling (RDS) to conduct a cross-sectional behavioral surveillance survey of PWID in two cities of Mozambique lasting six months. Participants were persons who had ever injected drugs without a prescription. Participants completed a behavioral questionnaire and provided blood specimens for HIV, hepatitis B surface antigen (HBsAg) and hepatitis C virus antibody (anti-HCV) testing. We performed RDS-adjusted analysis in R 3.2 using RDSAT 7.1 weights.

Results

We enrolled 353 PWID in Maputo and 139 in Nampula/Nacala; approximately 95% of participants were men. Disease prevalence in Maputo and Nampula/Nacala, respectively, was 50.1 and 19.9% for HIV, 32.1 and 36.4% for HBsAg positivity, and 44.6 and 7.0% for anti-HCV positivity. Additionally, 8% (Maputo) and 28.6% (Nampula/Nacala) of PWID reported having a genital sore or ulcer in the 12 months preceding the survey. Among PWID who injected drugs in the last month, 50.3% (Maputo) and 49.6% (Nampula/Nacala) shared a needle at least once that month. Condomless sex in the last 12 months was reported by 52.4% of PWID in Maputo and 29.1% in Nampula/Nacala. Among PWID, 31.6% (Maputo) and 41.0% (Nampula/Nacala) had never tested for HIV. In multivariable analysis, PWID who used heroin had 4.3 (Maputo; 95% confidence interval [CI]: 1.2, 18.2) and 2.3 (Nampula/Nacala; 95% CI: 1.2, 4.9) greater odds of having HIV.

Conclusion

Unsafe sexual behaviors and injection practices are frequent among PWID in Mozambique, and likely contribute to the disproportionate burden of disease we found. Intensified efforts in prevention, care, and treatment specific for PWID have the potential to limit disease transmission.
Literature
3.
go back to reference Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192–207.CrossRef Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192–207.CrossRef
4.
go back to reference Haysom S, Gastrow P, Shaw M. The heroin coast: a political economy along the eastern African seaboard. ENACT Res Pap. 2018;4. Available from: https://globalinitiative.net/the-heroin-coast-a-political-economy-along-the-eastern-african-seaboard/ Haysom S, Gastrow P, Shaw M. The heroin coast: a political economy along the eastern African seaboard. ENACT Res Pap. 2018;4. Available from: https://​globalinitiative​.​net/​the-heroin-coast-a-political-economy-along-the-eastern-african-seaboard/​
5.
go back to reference HIV/AIDS (UNAIDS) JUNP on. The gap report. Geneva UNAIDS, vol. 3; 2014. HIV/AIDS (UNAIDS) JUNP on. The gap report. Geneva UNAIDS, vol. 3; 2014.
6.
go back to reference Needle R, Fu J, Beyrer C, Loo V, Abdul-Quader AS, McIntyre JA, et al. PEPFAR’s evolving HIV prevention approaches for key populations—people who inject drugs, men who have sex with men, and sex workers: progress, challenges, and opportunities. JAIDS J Acquir Immune Defic Syndr. 2012;60:S145–51.CrossRef Needle R, Fu J, Beyrer C, Loo V, Abdul-Quader AS, McIntyre JA, et al. PEPFAR’s evolving HIV prevention approaches for key populations—people who inject drugs, men who have sex with men, and sex workers: progress, challenges, and opportunities. JAIDS J Acquir Immune Defic Syndr. 2012;60:S145–51.CrossRef
7.
go back to reference Matiko E, Khatib A, Khalid F, Welty S, Said C, Ali A, et al. HIV prevalence and risk behaviors among people who inject drugs in two serial cross-sectional respondent-driven sampling surveys, Zanzibar 2007 and 2012. AIDS Behav. 2014;19(1):36–45. Matiko E, Khatib A, Khalid F, Welty S, Said C, Ali A, et al. HIV prevalence and risk behaviors among people who inject drugs in two serial cross-sectional respondent-driven sampling surveys, Zanzibar 2007 and 2012. AIDS Behav. 2014;19(1):36–45.
8.
go back to reference Larney S, Peacock A, Leung J, Colledge S, Hickman M, Vickerman P, et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Lancet Glob Health. 2017;5(12):e1208–20.CrossRef Larney S, Peacock A, Leung J, Colledge S, Hickman M, Vickerman P, et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review. Lancet Glob Health. 2017;5(12):e1208–20.CrossRef
9.
go back to reference MacAllister J, Sherwood J, Galjour J, Robbins S, Zhao J, Dam K, et al. A comprehensive review of available epidemiologic and HIV service data for female sex workers, men who have sex with men, and people who inject drugs in select West and Central African countries. J Acquir Immune Defic Syndr 1999. 2015;68(Suppl 2):S83–90.CrossRef MacAllister J, Sherwood J, Galjour J, Robbins S, Zhao J, Dam K, et al. A comprehensive review of available epidemiologic and HIV service data for female sex workers, men who have sex with men, and people who inject drugs in select West and Central African countries. J Acquir Immune Defic Syndr 1999. 2015;68(Suppl 2):S83–90.CrossRef
10.
go back to reference Petersen Z, Myers B, van Hout M-C, Plüddemann A, Parry C. Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries. Harm Reduct J. 2013;10:13.CrossRef Petersen Z, Myers B, van Hout M-C, Plüddemann A, Parry C. Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries. Harm Reduct J. 2013;10:13.CrossRef
11.
go back to reference Harm Reduction International. The Global State of Harm Reduction 2016. K Stone Ed. 2016; Harm Reduction International. The Global State of Harm Reduction 2016. K Stone Ed. 2016;
12.
go back to reference Botão C, Horth RZ, Frank H, Cummings B, Inguane C, Sathane I, et al. Prevalence of HIV and associated risk factors among long distance truck drivers in Inchope, Mozambique, 2012. AIDS Behav. 2016;20(4):811–20.CrossRef Botão C, Horth RZ, Frank H, Cummings B, Inguane C, Sathane I, et al. Prevalence of HIV and associated risk factors among long distance truck drivers in Inchope, Mozambique, 2012. AIDS Behav. 2016;20(4):811–20.CrossRef
13.
go back to reference Nalá R, Cummings B, Horth R, Inguane C, Benedetti M, Chissano M, et al. Men who have sex with men in Mozambique: identifying a hidden population at high-risk for HIV. AIDS Behav. 2015;19(2):393–404.CrossRef Nalá R, Cummings B, Horth R, Inguane C, Benedetti M, Chissano M, et al. Men who have sex with men in Mozambique: identifying a hidden population at high-risk for HIV. AIDS Behav. 2015;19(2):393–404.CrossRef
14.
go back to reference Viegas EO, Tembe N, Macovela E, Gonçalves E, Augusto O, Ismael N, et al. Incidence of HIV and the Prevalence of HIV, Hepatitis B and Syphilis among Youths in Maputo, Mozambique: A Cohort Study. Blackard J. PLos One. 2015;10(3):e0121452.CrossRef Viegas EO, Tembe N, Macovela E, Gonçalves E, Augusto O, Ismael N, et al. Incidence of HIV and the Prevalence of HIV, Hepatitis B and Syphilis among Youths in Maputo, Mozambique: A Cohort Study. Blackard J. PLos One. 2015;10(3):e0121452.CrossRef
15.
go back to reference Baltazar CS, Horth R, Inguane C, Sathane I, César F, Ricardo H, et al. HIV prevalence and risk behaviors among Mozambicans working in south African mines. AIDS Behav. 2015;19(Suppl 1):S59–67.CrossRef Baltazar CS, Horth R, Inguane C, Sathane I, César F, Ricardo H, et al. HIV prevalence and risk behaviors among Mozambicans working in south African mines. AIDS Behav. 2015;19(Suppl 1):S59–67.CrossRef
16.
go back to reference Ministério da Saúde (MISAU, Instituto Nacional de Estatística (INE), ICF Internacional. Inquérito de Indicadores de Imunização, Malária e HIV/SIDA em Moçambique 2015. Maputo, Moçambique. Rockville, Maryland, EUA: INS, INE e ICF. Ministério da Saúde (MISAU, Instituto Nacional de Estatística (INE), ICF Internacional. Inquérito de Indicadores de Imunização, Malária e HIV/SIDA em Moçambique 2015. Maputo, Moçambique. Rockville, Maryland, EUA: INS, INE e ICF.
17.
go back to reference Spiller MW, Cameron C, Heckathorn DD. RDSAT 7.1 User Manual. Ithaca: Cornell University; 2012. Spiller MW, Cameron C, Heckathorn DD. RDSAT 7.1 User Manual. Ithaca: Cornell University; 2012.
18.
go back to reference Dwyer-Lindgren L, Cork MA, Sligar A, Steuben KM, Wilson KF, Provost NR, et al. Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017. Nature. 2019;570(7760):189–93.CrossRef Dwyer-Lindgren L, Cork MA, Sligar A, Steuben KM, Wilson KF, Provost NR, et al. Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017. Nature. 2019;570(7760):189–93.CrossRef
19.
go back to reference Scheibe A, Young K, Moses L, Basson RL, Versfeld A, Spearman CW, et al. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey. Harm Reduct J. 2019;16(1):28.CrossRef Scheibe A, Young K, Moses L, Basson RL, Versfeld A, Spearman CW, et al. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey. Harm Reduct J. 2019;16(1):28.CrossRef
20.
go back to reference Koziel MJ, Peters MG. Viral hepatitis in HIV infection. N Engl J Med. 2007;356(14):1445–54.CrossRef Koziel MJ, Peters MG. Viral hepatitis in HIV infection. N Engl J Med. 2007;356(14):1445–54.CrossRef
21.
go back to reference MISAU, INS. Final report: the Mozambique integrated biological and behavioral survey among people who inject drugs, 2014. Maputo, Mozambique; 2017. MISAU, INS. Final report: the Mozambique integrated biological and behavioral survey among people who inject drugs, 2014. Maputo, Mozambique; 2017.
22.
go back to reference Heckathorn DD. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002;49(1):11–34.CrossRef Heckathorn DD. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002;49(1):11–34.CrossRef
23.
go back to reference Augusto G, Nalá R, Manjate R. Avaliação dos conhecimentos, atitudes, práticas e prevalência do HIV/SIDA em prisioneiros da Cadeia Central da machava e Centro de Reclusão Feminina de N’dlavela. Rev Médica Moçamb. 2006;9(1):21–8. Augusto G, Nalá R, Manjate R. Avaliação dos conhecimentos, atitudes, práticas e prevalência do HIV/SIDA em prisioneiros da Cadeia Central da machava e Centro de Reclusão Feminina de N’dlavela. Rev Médica Moçamb. 2006;9(1):21–8.
25.
go back to reference Chambal LM, Samo Gudo E, Carimo A, Corte Real R, Mabunda N, Maueia C, et al. HBV infection in untreated HIV-infected adults in Maputo, Mozambique. PLoS ONE. 2017;12(7):e0181836CrossRef Chambal LM, Samo Gudo E, Carimo A, Corte Real R, Mabunda N, Maueia C, et al. HBV infection in untreated HIV-infected adults in Maputo, Mozambique. PLoS ONE. 2017;12(7):e0181836CrossRef
27.
go back to reference Ross MW, McCurdy SA, Kilonzo GP, Williams ML, Leshabari MT. Drug use careers and blood-borne pathogen risk behavior in male and female Tanzanian heroin injectors. Am J Trop Med Hyg. 2008;79(3):338–43.CrossRef Ross MW, McCurdy SA, Kilonzo GP, Williams ML, Leshabari MT. Drug use careers and blood-borne pathogen risk behavior in male and female Tanzanian heroin injectors. Am J Trop Med Hyg. 2008;79(3):338–43.CrossRef
28.
go back to reference Plüddemann A, Parry CD, Flisher AJ, Jordaan E. Heroin users in Cape Town, South Africa: injecting practices, HIV-related risk behaviors, and other health consequences. J Psychoactive Drugs. 2008;40(3):273–9.CrossRef Plüddemann A, Parry CD, Flisher AJ, Jordaan E. Heroin users in Cape Town, South Africa: injecting practices, HIV-related risk behaviors, and other health consequences. J Psychoactive Drugs. 2008;40(3):273–9.CrossRef
29.
go back to reference Kurth AE, Cleland CM, Des Jarlais DC, Musyoki H, Lizcano JA, Chhun N, et al. HIV prevalence, estimated incidence, and risk behaviors among people who inject drugs in Kenya. JAIDS J Acquir Immune Defic Syndr. 2015;70(4):420–7.CrossRef Kurth AE, Cleland CM, Des Jarlais DC, Musyoki H, Lizcano JA, Chhun N, et al. HIV prevalence, estimated incidence, and risk behaviors among people who inject drugs in Kenya. JAIDS J Acquir Immune Defic Syndr. 2015;70(4):420–7.CrossRef
30.
go back to reference Tun W, Sheehy M, Broz D, Okal J, Muraguri N, Raymond HF, et al. HIV and STI prevalence and injection behaviors among people who inject drugs in Nairobi: results from a 2011 bio-behavioral study using respondent-driven sampling. AIDS Behav. 2015;19(Suppl 1):S24–35.CrossRef Tun W, Sheehy M, Broz D, Okal J, Muraguri N, Raymond HF, et al. HIV and STI prevalence and injection behaviors among people who inject drugs in Nairobi: results from a 2011 bio-behavioral study using respondent-driven sampling. AIDS Behav. 2015;19(Suppl 1):S24–35.CrossRef
31.
go back to reference Brewer DD. Knowledge of specific HIV transmission modes in relation to HIV infection in Mozambique. F1000Research. 2012;1:1.CrossRef Brewer DD. Knowledge of specific HIV transmission modes in relation to HIV infection in Mozambique. F1000Research. 2012;1:1.CrossRef
32.
go back to reference Asher AK, Hahn JA, Couture M-C, Maher K, Page K. People who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa. J Assoc Nurses AIDS Care. 2013;24(6):e35–44.CrossRef Asher AK, Hahn JA, Couture M-C, Maher K, Page K. People who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa. J Assoc Nurses AIDS Care. 2013;24(6):e35–44.CrossRef
33.
go back to reference Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet Lond Engl. 2001;357(9266):1397–401.CrossRef Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet Lond Engl. 2001;357(9266):1397–401.CrossRef
34.
go back to reference Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45.CrossRef Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45.CrossRef
35.
go back to reference Cruciani M, Wiessing L, Serpelloni G, Genetti B, Andreotti A, Iulia C, et al. Increasing prevalence of HIV infection among first time clients in Italian drug treatment services–is it sexual transmission? BMC Infect Dis. 2015;15(1):201.CrossRef Cruciani M, Wiessing L, Serpelloni G, Genetti B, Andreotti A, Iulia C, et al. Increasing prevalence of HIV infection among first time clients in Italian drug treatment services–is it sexual transmission? BMC Infect Dis. 2015;15(1):201.CrossRef
36.
go back to reference Mehta SH, Srikrishnan AK, Noble E, Vasudevan CK, Solomon S, Kumar MS, et al. Emergence of cocaine and methamphetamine injection among HIV-positive injection drug users in Northern and Western India. Drug Alcohol Depend. 2014;135:160–5.CrossRef Mehta SH, Srikrishnan AK, Noble E, Vasudevan CK, Solomon S, Kumar MS, et al. Emergence of cocaine and methamphetamine injection among HIV-positive injection drug users in Northern and Western India. Drug Alcohol Depend. 2014;135:160–5.CrossRef
37.
go back to reference Girardi E, Sabin CA, Antonella d’Arminio Monforte MD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. JAIDS J Acquir Immune Defic Syndr. 2007;46:S3–8.CrossRef Girardi E, Sabin CA, Antonella d’Arminio Monforte MD. Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. JAIDS J Acquir Immune Defic Syndr. 2007;46:S3–8.CrossRef
38.
go back to reference Reid SR. Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review. Harm Reduct J. 2009;6(1):24.CrossRef Reid SR. Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review. Harm Reduct J. 2009;6(1):24.CrossRef
39.
go back to reference Otiashvili D, Kirtadze I, Vardanashvili I, Tabatadze M, Ober AJ. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia. Harm Reduct J. 2019;16(1):21.CrossRef Otiashvili D, Kirtadze I, Vardanashvili I, Tabatadze M, Ober AJ. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia. Harm Reduct J. 2019;16(1):21.CrossRef
40.
go back to reference Kan M, Garfinkel DB, Samoylova O, Gray RP, Little KM. Social network methods for HIV case-finding among people who inject drugs in Tajikistan. J Int AIDS Soc. 2018;21(Suppl 5):e25139.CrossRef Kan M, Garfinkel DB, Samoylova O, Gray RP, Little KM. Social network methods for HIV case-finding among people who inject drugs in Tajikistan. J Int AIDS Soc. 2018;21(Suppl 5):e25139.CrossRef
41.
go back to reference Frimpong JA, D’Aunno T, Jiang L. Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study. Am J Public Health. 2014;104(6):e75–82.CrossRef Frimpong JA, D’Aunno T, Jiang L. Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study. Am J Public Health. 2014;104(6):e75–82.CrossRef
Metadata
Title
High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique
Authors
Cynthia Semá Baltazar
Roberta Horth
Makini Boothe
Isabel Sathane
Peter Young
Denise Chitsondzo Langa
Manuel Condula
Helena Ricardo
Liliana Dengo Baloi
Beverley Cummings
Nicolas Schaad
Lídia Gouveia
Eugénia Teodoro
Henry F. Raymond
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2019
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-019-4655-2

Other articles of this Issue 1/2019

BMC Infectious Diseases 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.